ReviewMayo Clinic proceedings2011
Update on medications with adverse skeletal effects.
Review in Mayo Clinic proceedings, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Risk factors for and incidence of osteoporosis in patients with breast cancer by gender : a nationwide cohort study.Scientific reports · 2025Article
- Impact of Medications for Stable Angina Pectoris on Osteoporosis: A Review of Current Evidence.Journal of multidisciplinary healthcare · 2025Review
- Probiotics in Orthopedics: From Preclinical Studies to Current Applications and Future Perspective.Microorganisms · 2023Review
- PFAS and Potential Adverse Effects on Bone and Adipose Tissue Through Interactions With PPARγ.Endocrinology · 2021Review
- Commonly Prescribed and Over-the-Counter Drugs as Secondary Causes of Osteoporosis-Part Two.Integrative medicine (Encinitas, Calif.) · 2021Article
- Bovine Hydroxyapatite-Based Bone Scaffold with Gentamicin Accelerates Vascularization and Remodeling of Bone Defect.International journal of biomaterials · 2021Article
- Tricyclic Antidepressant Use and Risk of Fractures: A Meta-Analysis of Cohort Studies through the Use of Both Frequentist and Bayesian Approaches.Journal of clinical medicine · 2020Review
- Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.European journal of clinical pharmacology · 2019Article
- [Immunosuppressive treatment and bone healing].Der Unfallchirurg · 2019Review
- Leprosy Reactions In Childhood: A Prospective Cohort Study In The Brazilian Amazon.Infection and drug resistance · 2019Article
- Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study.Breast cancer research : BCR · 2018Article
- The Impact of Psychotropic Medications on Bone Health in Youth.Current psychiatry reports · 2018Review
- The Beneficial Effect of Proanthocyanidins and Icariin on Biochemical Markers of Bone Turnover in Rats.International journal of molecular sciences · 2018Article
- Critical gaps in the medical knowledge base of eating disorders.Eating and weight disorders : EWD · 2018Review
- Article
- Assessment and clinical management of bone disease in adults with eating disorders: a review.Journal of eating disorders · 2017Review
- Are selective serotonin reuptake inhibitors associated with fractures?Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2016Article
- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2015Article
- Role of flavonoids on oxidative stress and mineral contents in the retinoic acid-induced bone loss model of rat.European journal of nutrition · 2014Article
- Skeletal manifestations of treatment of breast cancer.Current osteoporosis reports · 2013Review
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients rely on their primary care physician to manage multiple, often chronic medical conditions that require prescription medications. Balancing the risk to benefit of treatments can be challenging and requires that the primary care physician stay abreast of new information regarding risks and benefits. The number of medications with reported adverse effects on skeletal health is expanding. This review focuses on medications recently added to the list of "bad to the bone" drugs and on recent advances in management of glucocorticoid-induced osteoporosis. A practical approach to assessing and managing the skeletal risks is outlined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.